ezetimibe

Generic: ezetimibe

Labeler: ohm laboratories inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ezetimibe
Generic Name ezetimibe
Labeler ohm laboratories inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ezetimibe 10 mg/1

Manufacturer
Ohm Laboratories Inc.

Identifiers & Regulatory

Product NDC 51660-200
Product ID 51660-200_12e7e79e-85d0-0c5d-e063-6394a90a8b78
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207311
Listing Expiration 2026-12-31
Marketing Start 2017-06-12

Pharmacologic Class

Established (EPC)
dietary cholesterol absorption inhibitor [epc]
Physiologic Effect
decreased cholesterol absorption [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51660200
Hyphenated Format 51660-200

Supplemental Identifiers

RxCUI
349556
UPC
0351660200300 0351660200904
UNII
EOR26LQQ24
NUI
N0000008553 N0000175911

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ezetimibe (source: ndc)
Generic Name ezetimibe (source: ndc)
Application Number ANDA207311 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 500 TABLET in 1 BOTTLE (51660-200-05)
  • 30 TABLET in 1 BOTTLE (51660-200-30)
  • 90 TABLET in 1 BOTTLE (51660-200-90)
source: ndc

Packages (3)

Ingredients (1)

ezetimibe (10 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "12e7e79e-85d0-0c5d-e063-6394a90a8b78", "openfda": {"nui": ["N0000008553", "N0000175911"], "upc": ["0351660200300", "0351660200904"], "unii": ["EOR26LQQ24"], "rxcui": ["349556"], "spl_set_id": ["5b3842f6-c80a-47b8-8a82-b69e465b05f7"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "pharm_class_epc": ["Dietary Cholesterol Absorption Inhibitor [EPC]"], "manufacturer_name": ["Ohm Laboratories Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (51660-200-05)", "package_ndc": "51660-200-05", "marketing_start_date": "20170612"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (51660-200-30)", "package_ndc": "51660-200-30", "marketing_start_date": "20170612"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (51660-200-90)", "package_ndc": "51660-200-90", "marketing_start_date": "20170612"}], "brand_name": "Ezetimibe", "product_id": "51660-200_12e7e79e-85d0-0c5d-e063-6394a90a8b78", "dosage_form": "TABLET", "pharm_class": ["Decreased Cholesterol Absorption [PE]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "product_ndc": "51660-200", "generic_name": "Ezetimibe", "labeler_name": "Ohm Laboratories Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ezetimibe", "active_ingredients": [{"name": "EZETIMIBE", "strength": "10 mg/1"}], "application_number": "ANDA207311", "marketing_category": "ANDA", "marketing_start_date": "20170612", "listing_expiration_date": "20261231"}